NGVT icon

Ingevity

47.20 USD
+0.74
1.59%
At close Jan 17, 4:00 PM EST
After hours
47.20
+0.00
0.00%
1 day
1.59%
5 days
24.67%
1 month
8.76%
3 months
32.96%
6 months
1.51%
Year to date
19.37%
1 year
17.88%
5 years
-42.83%
10 years
100.85%
 

About: Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Employees: 1,700

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 3 (+2) [Q3]

74% more call options, than puts

Call options by funds: $82K | Put options by funds: $47K

13% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 77

2.64% more ownership

Funds ownership: 96.77% [Q2] → 99.41% (+2.64%) [Q3]

9% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 43

2% less funds holding

Funds holding: 265 [Q2] → 260 (-5) [Q3]

8% less capital invested

Capital invested by funds: $1.54B [Q2] → $1.41B (-$128M) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$47
0%
upside
Avg. target
$47
0%
upside
High target
$47
0%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
BMO Capital
John McNulty
42% 1-year accuracy
20 / 48 met price target
0%downside
$47
Market Perform
Maintained
31 Oct 2024

Financial journalist opinion

Based on 4 articles about NGVT published over the past 30 days

Neutral
Zacks Investment Research
11 hours ago
NGVT to Evaluate Strategic Alternatives for Industrial Specialties
Ingevity plans to review strategic alternatives for the Performance Chemicals Industrial Specialties product line to increase its shareholder value.
NGVT to Evaluate Strategic Alternatives for Industrial Specialties
Neutral
Business Wire
4 days ago
Ingevity announces plans to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity explores strategic alternatives for Industrial Specialties product line and CTO refinery; releases preliminary 2024 financial results.
Ingevity announces plans to explore strategic alternatives for Performance Chemicals Industrial Specialties product line and North Charleston CTO refinery; releases preliminary 2024 financial results
Neutral
Business Wire
4 days ago
Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcast
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcast.
Ingevity announces dates for fourth-quarter and full year 2024 earnings release and webcast
Positive
Zacks Investment Research
2 weeks ago
Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?
NGVT gains on the repositioning of its Performance Chemicals segment, strategic acquisitions and actions to drive growth.
Ingevity Stock Up 23% in 3 Months: What's Driving the Rally?
Positive
Zacks Investment Research
1 month ago
Is Ingevity (NGVT) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Ingevity (NGVT) Stock Undervalued Right Now?
Neutral
Business Wire
1 month ago
Ingevity elects Kevin Willis to its board of directors
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Accomplished chemical industry CFO brings substantial finance, capital management expertise and experience driving corporate transformation.
Ingevity elects Kevin Willis to its board of directors
Positive
Zacks Investment Research
1 month ago
Here's Why You Should Add Ingevity Stock to Your Portfolio
NGVT benefits from the repositioning of its Performance Chemicals segment to rationalize its manufacturing footprint and strategic acquisitions.
Here's Why You Should Add Ingevity Stock to Your Portfolio
Neutral
Zacks Investment Research
1 month ago
Zacks Industry Outlook Axalta Coating Systems, Ingevity and AdvanSix
Axalta Coating Systems, Ingevity and AdvanSix have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Axalta Coating Systems, Ingevity and AdvanSix
Neutral
Zacks Investment Research
1 month ago
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Soft end-market demand dampens the prospects of the Zacks Chemicals Specialty industry. AXTA, NGVT and ASIX are set to gain from strategic actions to navigate the ongoing challenges.
3 Chemical Specialty Stocks to Watch Amid Industry Challenges
Positive
Zacks Investment Research
1 month ago
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
Charts implemented using Lightweight Charts™